Dr. Farzaneh Banki obtained her medical degree from the University of Montreal, Canada, in 1996. She subsequently completed her internship and general surgery residency at the University of Southern California (USC), including a year of clinical research in the esophageal motility laboratory. She acquired further experience in the treatment of esophageal disease during her thoracic and foregut fellowship at USC before working for a year as a clinical fellow at Response Genetics, Inc., to identify the role of plasma DNA as a diagnostic tool in the treatment of patients with esophageal cancer.
After completing her training in cardiothoracic surgery at the University of Washington in Seattle in 2007, she served in the Department of Surgery at USC from July 2007-2009. Dr. Banki became a member of the faculty at McGovern Medical School at UTHealth in Houston in 2009.
As Professor of Surgery at McGovern and Director of the Esophageal Disease Center at Memorial Hermann Southeast Hospital, Dr. Banki focuses on the treatment of benign and malignant diseases of the esophagus and lungs. Her clinical interests include the diagnosis and treatment of gastroesophageal reflux disease (GERD), esophageal motility disorder, malignant diseases of the esophagus and stomach, as well as benign and malignant disease of the lungs and airway.
Her focus of research includes the role of plasma DNA in the screening and diagnosis of primary, metastatic and recurrent esophageal cancer, diagnosis and treatment of complex hiatal hernia, and treatment of achalasia.